Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Efficacy of Romosozumab and Denosumab Combined Treatment in Postmenopausal Osteoporosis Patients with Multiple Fragility Fractures

NCT06720350 is registered in ClinicalTrials.gov with Marmara University as lead sponsor.

NCT NCT06720350
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06720350 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Efficacy of Romosozumab and Denosumab Combined Treatment in Postmenopausal Osteoporosis Patients with Multiple Fragility Fractures
Lead sponsor
Marmara University
Phase
Phase 4
Overall status
Not yet recruiting
Start date
January 15, 2025
Completion date
December 15, 2026
Enrollment
60 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

osteoporosis in post-menopausal women